Results 121 to 130 of about 16,985 (220)

Deferoxamine Treatment Effectively Prevents Periodontitis Progression by Reducing Inflammation and Osteoclastogenesis in Experimental Periodontitis Rats

Journal of Inflammation Research
Yanlin Zhu,1,2 Shuwei Qiao,2,3 Yuxuan Pang,2,3 Huimin Wang,2,3 Yanmin Zhou1,2 1Department of Dental Implantology, Hospital of Stomatology, Jilin University, Changchun, People’s Republic of China; 2Jilin Provincial Key Laboratory of Tooth Development and ...
Zhu Y, Qiao S, Pang Y, Wang H, Zhou Y
doaj  

EFFECTS OF A SINGLE COURSE OF DEFEROXAMINE IN NEUROBLASTOMA PATIENTS [PDF]

, 1990
A phase II trial of a single 5-day course of deferoxamine in 9 patients with neuroblastomas was completed. Within 2 days of completion of treatment responses were observed in 7 of 9 patients and there was no drug toxicity. These responses were a decrease
A. Donfrancesco, D. Pileggi, G. Deb, CASTELLO, Manuel Adolfo, L. Helson, DOMINICI, Carlo   +5 more
core  

Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis [PDF]

, 2006
Most deaths in beta-thalassemia major result from cardiac complications due to iron overload. Differential effects on myocardial siderosis may exist between different chelators.
Gotsis, ED, Karagiorga, M, Berdoukas, V, Aessopos, A, Tanner, MA, Galanello, R, Pennell, DJ, Piga, A, Smith, GC, Westwood, MA, Ladis, V, Wonke, B   +11 more
core  

Cinnamaldehyde and its combination with deferoxamine ameliorate inflammation, ferroptosis and hematoma expansion after intracerebral hemorrhage in mice

Journal of Neuroinflammation
Intracerebral hemorrhage (ICH) is a most serious type of hemorrhagic stroke with a continuously rising incidence globally, without effective cure available.
Yulin Liu, Guoqiang Yang, Mengnan Liu, Yuwei Zhang, Houping Xu, Maryam Mazhar   +5 more
doaj   +1 more source

Effect of intravenous Deferoxamine concomitant use with blood transfusion on serum ferritin in thalassemia major patients [PDF]

Background: Subcutaneous Deferoxamineis often not tolerated by patients and its rejection leads to iron overload with its complications. So, other methods with better toleration and reduction of Deferoxamine consumption are necessary. The present study
عرقچین, سمیرا, فتحی, افشین, امانی, فیروز, فرزانه, اسماعیل   +3 more
core  

The impact of intravenous deferoxamine during the blood transfusion on reduction of serum ferritin in thalassemia patients [PDF]

Introduction: A blood transfusion in patients with thalassemia major is a important treatment base. Iron overload resulted from Long-term transfusion-related using iron chelators particularly by the deferoxamine can be reduced.
عرقچین, سمیرا, فتحی, افشین, امانی, فیروز   +2 more
core  

Hearing loss in Iranian thalassemia major patients treated with deferoxamine: A systematic review and meta-analysis

Caspian Journal of Internal Medicine, 2017
Background: Hearing disorders are reported in thalassemia patients treated with deferoxamine. This study aimed to assess hearing loss in Iranian thalassemia major patients treated with deferoxamine.
Gholamreza Badfar, Akram Mansouri, Masoumeh Shohani, Hamid Karimi, Zahra Khalighi, Shoboo Rahmati, Ali Delpisheh, Yousef Veisani, Ali Soleymani, Milad Azami   +9 more
doaj  

Comparative evaluation of microfluidic-synthesized nano-niosomes versus liposomal and micro-niosomal deferoxamine in murine iron overload models. [PDF]

Res Pharm Sci
Bazi A, Karami-Mohajeri S, Valandani HM, Jafari E, Oroojalian F, Pardakhty A, Khalilabadi RM.   +6 more
europepmc   +1 more source

Advancements in fire-related toxic gas detection and prophylactic strategies: A focus on cyanide concentration analysis and antidote efficacy in controlled smoke inhalation models. [PDF]

PLoS One
Tani J, Chen JL, Liao WC, Chen CH, Wang CH, Sun TH, Shiue YL, Tsai JW.   +7 more
europepmc   +1 more source

Deferoxamine Improves Radiation-Induced Peripheral Neuropathy. [PDF]

J Cell Mol Med
Lavin CV, Fazilat AZ, Kendig CB, Shibale P, Huang KX, Nemani S, Parker JB, Valencia C, Ailury NAR, Griffin M, Momeni A, Longaker MT, Wan DC.   +12 more
europepmc   +1 more source